Patients receiving subcutaneous daratumumab have less chair time and premedication than those receiving IV formulation, says ...

A quality-adjusted time without symptoms or toxicity analysis identified better outcomes for patients with RCC treated with belzutifan vs everolimus.

Levels of kidney injuring molecule–1 appear to be predictive of therapeutic benefit in patients with renal cell carcinoma.

Panelists discuss how patient portal use improves communication by allowing patients to report adverse effects with photos ...

Panelists discuss how patients newly diagnosed with multiple myeloma often face emotional and informational overload, but ...

A personalized neoantigen vaccine may be effective in patients with clear cell renal cell carcinoma, shared David A. Braun, ...

Oncology nurses can assess patients’ risk factors and advocate for preventive strategies that protect kidney function during ...

This is an actor portrayal of a hypothetical patient profile developed for educational purposes based on characteristics of ...

Oncology Nursing News connects oncology nurses and APPs with updates on therapy advances, side effect management, and patient-centered cancer care.

Panelists discuss treatment considerations for metastatic melanoma with high tumor burden, highlighting the preference for immune checkpoint combinations like nivolumab with relatlimab for durable ...